株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

肝外胆管癌:世界の治験動向

Extrahepatic Bile Duct Cancer Global Clinical Trials Review, H1, 2015

発行 GlobalData 商品コード 328412
出版日 ページ情報 英文 94 Pages
即納可能
価格
本日の銀行送金レート: 1USD=115.18円で換算しております。

2016年12月31日まで 年末キャンペーン割引: GlobalData社発行レポート
ご注意: ショッピングカートでは適用されませんので、割引価格についてはお問い合わせください

Back to Top
肝外胆管癌:世界の治験動向 Extrahepatic Bile Duct Cancer Global Clinical Trials Review, H1, 2015
出版日: 2015年02月27日 ページ情報: 英文 94 Pages
概要

当レポートでは、世界の肝外胆管癌治療薬の臨床試験について調査し、地域別の臨床試験数データ、試験段階、試験状況、採用テーマおよびスポンサー企業タイプ別の臨床試験データ、中断 (一時中止、廃止、打ち切り) された試験のリストなどを提供しています。

イントロダクション

  • 肝外胆管癌
  • 当レポートの概要

各地域における治験状況

  • 各国の治験件数と平均被験者数
    • アジア太平洋地域の主要国における治験件数
    • 欧州の主要5ヶ国における治験件数
    • 北米の主要国における治験件数

G7諸国での治験件数:癌治療薬の治験における肝外胆管癌の割合

G7諸国における段階別の治験件数

G7諸国での治験件数:進捗状況別

段階別の治験件数

  • 進行中の治験:段階別

進捗状況別の治験件数

治験の目標の達成状況

未完了の治験件数

一定期間に採用された被験者

スポンサーの種類別の治験件数

有望なスポンサー

肝外胆管癌治療薬の治験に携わっている主要企業

有望な薬剤

治験のプロファイル

  • 主要企業の治験の概要
    • AstraZeneca PLC
    • PrECOG, LLC.
    • 第一三共
  • 代表的な研究機関・病院の治験の概要
    • National Cancer Institute
    • Memorial Sloan Kettering Cancer Center
    • Massachusetts General Hospital
    • National Institutes of Health Clinical Center
    • North Central Cancer Treatment Group
    • University of Chicago
    • Mayo Clinic
    • SWOG
    • Northwestern University
    • Samsung Medical Center

5つの代表的な治験のプロファイル

付録

目次
Product Code: GDHC2584CTIDB

GlobalData's clinical trial report, "Extrahepatic Bile Duct Cancer Global Clinical Trials Review, H1, 2015" provides data on the Extrahepatic Bile Duct Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Extrahepatic Bile Duct Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Extrahepatic Bile Duct Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Extrahepatic Bile Duct Cancer
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
  • Clinical Trials by G7 Countries: Proportion of Extrahepatic Bile Duct Cancer to Oncology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Extrahepatic Bile Duct Cancer
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • AstraZeneca PLC
      • Clinical Trial Overview of AstraZeneca PLC
      • PrECOG, LLC.
      • Clinical Trial Overview of PrECOG, LLC.
      • Daiichi Sankyo Company, Limited
      • Clinical Trial Overview of Daiichi Sankyo Company, Limited
    • Clinical Trial Overview of Top Institutes / Government
      • National Cancer Institute
      • Clinical Trial Overview of National Cancer Institute
      • Memorial Sloan Kettering Cancer Center
      • Clinical Trial Overview of Memorial Sloan Kettering Cancer Center
      • Massachusetts General Hospital
      • Clinical Trial Overview of Massachusetts General Hospital
      • National Institutes of Health Clinical Center
      • Clinical Trial Overview of National Institutes of Health Clinical Center
      • North Central Cancer Treatment Group
      • Clinical Trial Overview of North Central Cancer Treatment Group
      • University of Chicago
      • Clinical Trial Overview of University of Chicago
      • Mayo Clinic
      • Clinical Trial Overview of Mayo Clinic
      • SWOG
      • Clinical Trial Overview of SWOG
      • Northwestern University
      • Clinical Trial Overview of Northwestern University
      • Samsung Medical Center
      • Clinical Trial Overview of Samsung Medical Center
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Extrahepatic Bile Duct Cancer Therapeutics, Global, Clinical Trials by Region, 2015*
  • Extrahepatic Bile Duct Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Extrahepatic Bile Duct Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015*
  • Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2015*
  • Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials, North America, Top Countries, 2015*
  • Proportion of Extrahepatic Bile Duct Cancer to Oncology Clinical Trials, G7 Countries (%), 2015*
  • Extrahepatic Bile Duct Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Extrahepatic Bile Duct Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Extrahepatic Bile Duct Cancer Therapeutics, Global, Clinical Trials by Phase, 2015*
  • Extrahepatic Bile Duct Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2015*
  • Extrahepatic Bile Duct Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Extrahepatic Bile Duct Cancer Therapeutics, Global, Withdrawn Clinical Trials, 2015*
  • Extrahepatic Bile Duct Cancer Therapeutics, Global, Terminated Clinical Trials, 2015*
  • Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Extrahepatic Bile Duct Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015*
  • Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2015*
  • Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by PrECOG, LLC., 2015*
  • Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Daiichi Sankyo Company, Limited, 2015*
  • Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2015*
  • Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2015*
  • Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2015*
  • Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institutes of Health Clinical Center, 2015*
  • Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by North Central Cancer Treatment Group, 2015*
  • Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Chicago, 2015*
  • Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2015*
  • Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by SWOG, 2015*
  • Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Northwestern University, 2015*
  • Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Samsung Medical Center, 2015*

List of Figures

  • Extrahepatic Bile Duct Cancer Therapeutics, Global, Clinical Trials by Region (%), 2015*
  • Extrahepatic Bile Duct Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Extrahepatic Bile Duct Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015*
  • Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015*
  • Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2015*
  • Proportion of Extrahepatic Bile Duct Cancer to Oncology Clinical Trials, G7 Countries (%), 2015*
  • Extrahepatic Bile Duct Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Extrahepatic Bile Duct Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Extrahepatic Bile Duct Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2015*
  • Extrahepatic Bile Duct Cancer Therapeutics, Global, Clinical Trials In Progress by Phase, 2015*
  • Extrahepatic Bile Duct Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Extrahepatic Bile Duct Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015*
  • Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • GlobalData Methodology
Back to Top